Visit Our New YouTube Channel for Helpful Tutorials and Answers to Common Technical Questions.

Products

VU0359595 | 857371

(1R,2R)-N-([S]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxamide

857371P

Powder

1 mg
$130.00
5 mg
$360.00
10 mg
$670.00

All Prices in US Dollars
Custom packaging is calculated at $4.00 per aliquot and will be charged at the time of shipping.

Custom Packaging: Before clicking add to cart, from the drop down arrow select custom packaging. Next, edit the quantities (and concentration for solutions) information. Finally, click add to cart.

  • Product
  • Data
  • Downloads
  • Reference
VU0359595 has been shown to selectively inhibit the PLD1 isoform at nM levels (see data below).
 
 
 
Molecular Formula
C25H29BrN4O2
Percent Composition
C 60.36%, H 5.88%, Br 16.06%, N 11.26%, O 6.43%
Purity
>99%
Stability
1 Years
Storage
-20°C
CAS Number
1246303-14-9
CAS Registry Number is a Registered Trademark of the American Chemical Society
Molecular Weight
497.427
Exact Mass
496.147
Synonyms
EVJ
VU0359595
Download
Notes
GIF Graphics File. 
GIF Graphics File. 
MDL Molfile. 
CDX File. 
Bruntz, R.C., H.E. Taylor, C.W. Lindsley, and H.A. Brown. (2013). Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells. J Biol Chem [PubMed]

Lewis, J.A., Scott, S.A., Lavieri, R., Buck, J.R., Selvy, P.E., Stoops, S.L., Armstrong, M.D., Brown, H.A., and C.W. Lindsley. (2009) Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I. Impact of alternative halogenated privileged structures for PLD1 specificity. Bioorganic and Medicinal Chemistry Letters. 19, 1916-1920. [PubMed]